|
|
|
January 2004 |
Substance-SpecificApplied Research Program |
|
Background |
The Agency for Toxic Substances and Disease
Registry’s (ATSDR) congressionally mandated Substance-Specific Applied
Research Program (SSARP) currently consists of a research agenda
for 60 top hazardous substances that is being accomplished through
successful partnerships with other federal agencies, universities,
and industry groups.
|
back to top |
|
Legislative Mandate |
The Comprehensive Environmental Response, Compensation,
and Liability Act of 1980 (CERCLA, or Superfund legislation)
requires ATSDR to carry out the following activities:
- Develop, jointly with the U.S. Environmental Protection Agency
(EPA), a priority list of hazardous substances found at waste
sites on EPA’s National
Priorities List (NPL).
- Prepare toxicological profiles for hazardous substances found
at NPL sites.
- Assure, in cooperation with the National Toxicology Program
(NTP), the initiation of a research program to address identified
data needs associated with the toxic substances, i.e., SSARP.
|
back to top |
|
Program Objectives |
- Address the substance-specific information needs of the public
and scientific community.
- Supply information necessary to improve the database used to
conduct comprehensive public health assessments of populations
living near hazardous waste sites.
- Establish linkages between levels of contaminants in the environment
and levels in human tissues and organs that are associated with
adverse health effects.
|
back to top |
|
Program Activities
and Status |
- Developed a Decision Guide in 1989 for determining
research priorities for hazardous substances found at waste sites
and in the environment.
- Established the Tri-agency Superfund Applied Research Committee
(TASARC) in 1991 to:
- Advise ATSDR on assigning priorities for mechanisms to address
research needs.
- Coordinate knowledge of research activities to avoid duplication
of research in other programs and under other authorities.
- Advise ATSDR on issues of science related to substance-specific
research needs.
- Maintain a scheduled forum that provides an overall review
of SSARP.
- Established a research agenda in 1991 for an initial 38 hazardous
substances - aldrin/dieldrin, arsenic, benzene, beryllium, cadmium,
carbon tetrachloride, chloroethane, chloroform, chromium, cyanide,
p,pðÀ-DDT, DDE, DDD, di(2-ethylhexyl) phthalate, lead,
mercury, methylene chloride, nickel, polychlorinated biphenyl
compounds (PCBs), polycyclic aromatic hydrocarbons (PAHs), which
include 15 substances, selenium, tetrachloroethylene, toluene,
trichloroethylene, vinyl chloride, and zinc. Comments from the
public were invited.
- Expanded the SSARP in 1997 by identifying research needs for
12 additional substances (chlordane, 1,2-dibromo-3-chloropropane,
di-n-butyl phthalate, disulfoton, endrin, endosulfan, heptachlor,
hexachlorobutadiene, hexachlorocyclohexane, manganese, methoxychlor,
and toxaphene).
- Announced research needs in 2003 for 10 additional substances
(asbestos, benzidine, chlorinated dibenzo-p-dioxins, 1,2-dibromoethane,
1,2-dichloroethane, 1,1-dichloroethene, ethylbenzene, pentachlorophenol,
1,1,2,2,-tetrachloroethane, and total xylenes).
- Identified key mechanisms, with the oversight of TASARC, for
filling research needs,
including industry testing as a result of EPA rule-making, voluntary
industry testing (studies conducted by industry groups at no expense
to ATSDR), NTP testing, and direct ATSDR-supported testing, including
university-based research through a cooperative agreement with
the Minority Health Professions
Foundation (MHPF).
- To date, of 263 research needs identified for 60 substances,
62 research needs have been filled, and an additional 68 are currently
being addressed through various mechanisms.
|
back to top |
|
Examples of Research
Findings |
- Lower chlorinated Aroclors (commercial polychlorinated biphenyl
[PCB] mixtures) (e.g., Aroclor 1016 and Aroclor 1242), previously
thought to be less toxic, are capable of producing tumors in rats.
Subsequently, EPA used the data from this study to revise its
cancer slope factor for PCBs.
- Exposure to benzo(a)pyrene (BaP) may adversely affect reproductive
health. BaP and its break-down products accumulate in the testes
and ovaries of animals exposed to BaP by ingestion or inhalation.
Pathological changes were observed in the testes of male animals
exposed to BaP, as well as a dose-dependent decrease in the number
of active sperm.
- Developed a new ATSDR health guidance value (Minimal Risk Level)
of 0.2 mg/kg/day for methylene chloride for short-term exposure
via the oral route.
- Consumption of water containing large amounts of methylene chloride
(approximately 600-6000 mg of methylene chloride per liter of
water) may result in adverse health effects on the central nervous
system, liver, and the development of newborns.
- Infants may be at risk for neurobehavioral effects from exposure
to maternal blood lead levels that are less than 10 µg/dL.
These results among African American subjects corroborate findings
in other populations on the effects of low-level, prenatal lead
exposures.
- Lead accumulated preferentially in the brain of young animals
exposed to blood lead levels that are less than 5 µg/dL.
This provides biological evidence that even low levels of lead
can reach the brain and may cause adverse health effects during
early developmental stages.
- Hydroxylated metabolites of PCBs, which are considered to be
strong indicators of naturally occurring aerobic biodegradation,
were detected in sediment samples collected from PCB-contaminated
sites in the upper Hudson River.
|
back to top |
|
Program Impact |
The ATSDR SSARP, to date, has accomplished the
following:
- Filled 62 research needs for populations potentially exposed
to hazardous environmental substances.
- Demonstrated the effectiveness of successful partnerships with
other federal agencies, universities, and industry groups in filling
critical public health research
needs.
- Filled 19 public health research needs through university-based
research via an agreement with the MHPF.
- Addressed 18 research needs for 8 substances using an EPA/ATSDR
test rule currently under development.
- Established Memoranda of Understanding with four private sector
organizations (American Chemistry Council, Electric Power Research
Institute, Inc., General Electric Company, and Halogenated Solvents
Industry Alliance, Inc.). These industry groups are conducting
studies to fill at least 16 research needs associated with five
substances at no expense to the agency, resulting in a savings
of about $10 million in research costs to ATSDR.
|
back to top |
|
Future Directions |
Through the SSARP, ATSDR plans to broaden efforts
to fill research needs through outreach to a wider range of potential
federal and private-sector partners, including international organizations.
|
back to top |
|
Selected References |
Agency for Toxic Substances and Disease Registry.
Decision guide for identifying substance-specific data needs related
to toxicological profiles; Notice. 1989. Fed Regist 54: 37618-37634.
Agency for Toxic Substances and Disease Registry.
Announcement of final priority data needs for 38 hazardous substances.
1992. Fed Regist 57: 54150-54159.
Agency for Toxic Substances and Disease Registry.
Announcement of final priority data needs for 12 priority hazardous
substances and call for voluntary research proposals. 1997. Fed
Regist 62: 40820-40828.
Agency for Toxic Substances and Disease Registry.
Update on the status of the Superfund Substance-Specific Applied
Research Program. 2002. Fed Regist 67: 4836-4854.
Agency for Toxic Substances and Disease Registry.
Announcement of final priority data needs for 10 priority hazardous
substances. 2003. Fed Regist 68: 22704-22709.
Archibong AE, Inyang F, Ramesh A, et al. 2002.
Alteration of pregnancy related hormones and fetal survival in F-344
rats exposed by inhalation to benzo(a)pyrene. Reprod Toxicol 16(6):801-808.
Areola OO, Williams-Johnson M, Jadhav, AL.
1999. Relationship between lead accumulation in blood and soft tissues
of rats subchronically exposed to low levels of lead. Toxic Subst
Mech 18:1-13.
Emory E, Pattillo R, Archibold E, et al. 1999.
Neurobehavioral effects of low level lead exposure in human neonates.
Am J Obstet Gynecol: 181(1):S2-11.
Emory E, Ansari Z, Pattillo R, et al. 2003.
Maternal blood lead effects on infant intelligence at age 7 months.
Am J Obstet Gynecol: 188(4):S26-32.
General Electric Company. An assessment of
the chronic toxicity and oncogenicity of Aroclors 1016, 1242, 1254,
and 1260 administered in diet to rats. Final report (February 1997).
Available by contacting the Division of Toxicology, ATSDR.
General Electric Company. Metabolite detection
as a tool for the determination of naturally occurring aerobic PCB
biodegradation. Final report (May 14, 1999). Available by contacting
the Division of Toxicology, ATSDR.
Halogenated Solvents Industry Alliance, Inc.
Addressing priority data needs for methylene chloride with physiologically
based pharmacokinetic modeling. Final report (February 4, 1997).
Available by contacting the Division of Toxicology, ATSDR.
Inyang F, Ramesh A, Kopsombut P, et al. 2003.
Disruption of testicular steroidogenesis and epdidymal function
by inhaled benzo(a)pyrene. Reprod Toxicol 17(5):527-537.
Jadhav AL and Areola OO. 1997. Alteration in
acquisition and pattern of responding in rats subchronically exposed
to low levels of lead. Res Commun Biol Psychol Psych 22(1&2):11-24.
Ramesh A, Hood DB, Inyang F, et al. 2002. Comparative
metabolism, bioavailability and toxicokinetics of benzo(a)pyrene
in rats after acute oral, inhalation, and intravenous administration.
PAC 22:969-980.
Ramesh A, Inyang F, Hood DB, et al. 2001. Metabolism,
bioavailability, and toxicokinetics of benzo(a)pyrene in F-344 rats
following oral administration. Exp Toxicol Pathol 53:275-290.
Stevens, Y-W, Williams-Johnson, MM, De Rosa,
CT, et al. 2002. Findings and accomplishments of ATSDRs Superfund-mandated
substance-specific applied research program. Int J Hyg Environ Health
205: 29-39.
|
back to top |
|
Where can I get
more information? |
For more information about the Computational
Toxicology Laboratory, contact
Agency for Toxic Substances and Disease Registry
Division of Toxicology
1600 Clifton Road NE, Mailstop F-32
Atlanta, GA 30333
Phone: 1-888-42-ATSDR (1-888-422-8737)
FAX: (770)-488-4178
Email: ATSDRIC@cdc.gov
|
back to top |
|
|